Laparoscopic excision of ovarian endometriomas: does post-operative medical treatment prevent recurrence?

In: The Journal of the American Association of Gynecologic Laparoscopists · 1994 · vol. 1(4) , pp. S20 · doi:10.1016/s1074-3804(05)80932-6 · PMID:9073710 · W2087750711
article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study investigated whether post-operative medical treatment following laparoscopic excision of ovarian endometriomas affects recurrence rates.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Of 103 women undergoing laparoscopic excision of ovarian endometriomas, 41 patients were prescribed to 3 to 6 months therapy with GnRH analogs or danazol postoperatively and 62 received no additional treatment. No significant difference in extent of disease was present between the two groups at the time of surgery. Follow-up longer than 3 months, including a sonogram, was available for 40 patients of the treatment group and for 42 patients of the group receiving no additional treatment. Four recurrences (10%) at 3, 12, 16 and 21 months occurred in the treatment group, and 3 recurrences (7%) at 5, 6 and 6 months occurred in the no-treatment group (p=NS). Postoperative medical treatment does not prevent recurrence of laparoscopically excised ovarian endometriomas.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-02T06:31:42.897446+00:00
License: CC0 · commercial use OK